跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 71 条关于
“INNOCARE”
全部
71
临床试验
18
药物
4
机构
5
资讯
44
去年
InnoCare Doses First Subject in Phase III Trial of TYK2 Inhibitor ICP-332 for Atopic Dermatitis
去年
InnoCare Pharma's ICP-488 Demonstrates Positive Phase II Results for Psoriasis
9个月前
InnoCare Initiates Global Phase II Trial of TYK2 Inhibitor Soficitinib for Prurigo Nodularis Treatment
去年
InnoCare Doses First Subject in Phase III Trial of TYK2 Inhibitor ICP-332 for Atopic Dermatitis
去年
InnoCare Urologics wins FDA nod for urinary safety catheter - MassDevice
11个月前
Zenas BioPharma Acquires Three Autoimmune Drugs from InnoCare in $2 Billion Deal
去年
InnoCare and KeyMed Strike $520M Licensing Deal with Prolium for Novel CD20xCD3 Bispecific Antibody
2年前
InnoCare Advances Dual Regulatory Milestones with Tafasitamab BLA Acceptance and BCL2 Inhibitor ICP-248 Clinical Trial Approval in China
去年
InnoCare Pharma's TYK2 Inhibitor ICP-488 Shows Promising Phase II Results for Psoriasis Treatment
去年
InnoCare Presents Promising Clinical Data for Multiple Oncology Pipeline Candidates at Major Medical Conferences
第 1 页,共 5 页
上一页
下一页